2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
11.86% |
13.89% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.59% |
5.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
22.49% |
15.22% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.86% |
-2.73% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.71% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.65% |
6.04% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-6.24% |
0.59% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.47% |
7.14% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.5% |
5.04% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.41% |
6.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
40.47%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
-8.6% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
11.69% |
11.15% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.99% |
7.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
22.55% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.85% |
-3.83% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.83% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.5% |
3.45% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.84% |
-6.71% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.15% |
3.06% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.77% |
3.06% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.77% |
1.45% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.71% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
47.82%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
APLS |
Sell
All
|
-8.89% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.62% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
10.79% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.65% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
22.45% |
10.8% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.37% |
33.75% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.92% |
-5.46% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.19% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.47% |
0.26% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.54% |
0.85% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.07% |
6.89% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.21% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.84% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.85% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
30.03%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.72% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.67% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.03% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.73% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
21.5% |
7.2% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.29% |
33.96% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.75% |
-7.1% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
18.67% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.41% |
0.63% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.52% |
15.41% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-5.99% |
7.17% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.31% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.21% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.7% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
20.96%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
11.15% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.17% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.8% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
13.03% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
21.32% |
5.05% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.17% |
14.37% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.65% |
-9.84% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
19.93% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
19.2% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.46% |
0% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.51% |
16.54% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.28% |
3.86% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.37% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.95% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.77% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.59% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.03% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.06% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.83% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.72% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
21.31% |
5.72% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.44% |
3.44% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.85% |
-6.01% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
20.4% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
20.39% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.58% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.25% |
3.61% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.76% |
5.44% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-6.12% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.9% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.25% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.31% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.15% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.59% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.8% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
21.08% |
3.96% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.55% |
4.69% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
6.23% |
-0.55% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
20.52% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.76% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.35% |
2.72% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.85% |
4.42% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-6.02% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-6.02% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
22.52%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.53% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.44% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.45% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.8% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
11.46% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.38% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
20.52% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
18.18% |
-10.38% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.27% |
0% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
6.27% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.07% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.52% |
0.15% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.69% |
7.14% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.91% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.83% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.63% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.66% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.59% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
11.12% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.34% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
16.41% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
19.25% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
19.25% |
0% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.05% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.11% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-6.21% |
-0.3% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.81% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-5.81% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
-9.7% |
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.75% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.92% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.37% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.46% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.28% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
11.2% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.03% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
16.32% |
0% |
2024-08-28 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-6% |
-0.42% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.93% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.03% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-6.03% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
34.64%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
4.72% |
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
13.75% |
6.09% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
9.67% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.76% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.46% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.54% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.49% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
11.24% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.24% |
0% |
2024-08-27 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.79% |
0.84% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.84% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
24.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
13.12% |
-0.59% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
9.91% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.01% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.3% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.09% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.55% |
6.03% |
2024-08-23 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.72% |
3.8% |
2024-07-31 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.07% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
47.82%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
12.94% |
-4.32% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
9.68% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.01% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.9% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.2% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.2% |
0% |
2024-08-23 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.71% |
6.33% |
2024-07-31 |
The percentage of cash held in the portfolio is:
42.79%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
12.95% |
-2.95% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
10.06% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.06% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.06% |
0% |
2024-08-22 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.47% |
9.07% |
2024-07-31 |
The percentage of cash held in the portfolio is:
62.35%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
13.15% |
-1.57% |
2024-07-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.75% |
4.43% |
2024-07-31 |
The percentage of cash held in the portfolio is:
92.61%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Buy
All
|
0.74% |
RCM |
Sell
All
|
7.37% |
Assets Rebalanced
None
2024-08-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
12.24% |
7.37% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
12.64% |
-4.91% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-5.81% |
6.55% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.17% |
13.71% |
2024-07-31 |
The percentage of cash held in the portfolio is:
86.1%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
13.64% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
10.47% |
-3.03% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
12.54% |
7.14% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
12.6% |
-7.66% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-6.24% |
2.34% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.52% |
10.34% |
2024-07-31 |
The percentage of cash held in the portfolio is:
76.14%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
1.39% |
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
10.64% |
-0.76% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
12.44% |
7.06% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
12.83% |
-5.3% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
14.78% |
3.67% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.2% |
2.25% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.62% |
8.02% |
2024-07-31 |
The percentage of cash held in the portfolio is:
61.13%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PDSB |
Sell
All
|
-10.51% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.56% |
-8.52% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.84% |
2.27% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
12.39% |
7.83% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
13.14% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
15.15% |
7.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.32% |
-0.76% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.86% |
2.95% |
2024-07-31 |
The percentage of cash held in the portfolio is:
51.1%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-11.82% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.52% |
-8.24% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.01% |
4.55% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
12.38% |
8.44% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
13.1% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.8% |
-3.84% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
2.9% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.44% |
3.13% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.3% |
-1.17% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-6.05% |
-0.84% |
2024-07-31 |
The percentage of cash held in the portfolio is:
36.2%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FATE |
Sell
All
|
-12.39% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.32% |
1.14% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.13% |
7.58% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
11.09% |
-1.15% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.92% |
-4.31% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.52% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.68% |
-3.09% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
2.92% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.11% |
2.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.1% |
0.31% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-6% |
-1.69% |
2024-07-31 |
The percentage of cash held in the portfolio is:
27.42%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
27.55% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.7% |
26.42% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.14% |
-1.7% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.34% |
8.33% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
11.23% |
-1% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.68% |
-7.9% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.41% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.81% |
-3.16% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
2.98% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
13.91% |
0% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.15% |
0.6% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.96% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
15.91%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.72% |
30.89% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.82% |
8.52% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.96% |
8.33% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
10.69% |
-2.61% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.85% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.27% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
12.09% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
13.02% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.57% |
-1.69% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
2.89% |
0% |
2024-07-30 |
PODD
Insulet Corporation
|
Sell |
-5.89% |
1.61% |
2024-07-19 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RMD |
Buy
All
|
-5.84% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.02% |
26.12% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.73% |
10.23% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.08% |
12.12% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
10.69% |
-0.19% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.69% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.53% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.64% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
12.49% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
12.49% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.49% |
0% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-5.79% |
0.85% |
2024-07-19 |
RMD
ResMed Inc.
|
Sell |
-6.05% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.86% |
23.69% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.94% |
11.93% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.67% |
7.58% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
10.67% |
-0.84% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.66% |
-3.05% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.87% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.52% |
0% |
2024-07-26 |
PODD
Insulet Corporation
|
Sell |
-5.75% |
2.09% |
2024-07-19 |
The percentage of cash held in the portfolio is:
33.55%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
48.75% |
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
11.4% |
35.31% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.74% |
19.76% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.69% |
6.96% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.9% |
7.58% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
11.09% |
0.92% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.49% |
-7% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
10.17% |
0% |
2024-07-25 |
PODD
Insulet Corporation
|
Sell |
-5.98% |
0.3% |
2024-07-19 |
The percentage of cash held in the portfolio is:
32.5%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Sell
All
|
20.09% |
ACAD |
Sell
All
|
16.37% |
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.91% |
28.79% |
2024-06-25 |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
11.58% |
14.55% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
10.45% |
26.56% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.39% |
18.17% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
11.78% |
20.17% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.85% |
9.09% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
11.11% |
3.07% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.96% |
0% |
2024-07-24 |
PODD
Insulet Corporation
|
Sell |
-5.94% |
-0.92% |
2024-07-19 |
The percentage of cash held in the portfolio is:
19.91%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
11.11% |
29.24% |
2024-06-25 |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
11.71% |
14.17% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
10.35% |
23.44% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.12% |
13.4% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
11.02% |
10.8% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.16% |
10.61% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
11.18% |
2.15% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-5.95% |
0.37% |
2024-07-19 |
The percentage of cash held in the portfolio is:
29.3%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Buy
All
|
-22.33% |
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
11.21% |
31.03% |
2024-06-25 |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
11.41% |
11.78% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
9.83% |
17.81% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.73% |
9.54% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.88% |
9.94% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.34% |
12.88% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
11.11% |
2% |
2024-07-18 |
FGEN
FibroGen, Inc.
|
Sell |
-6.36% |
-1.94% |
2024-06-28 |
PODD
Insulet Corporation
|
Sell |
-5.94% |
-0.04% |
2024-07-19 |
The percentage of cash held in the portfolio is:
36.79%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.98% |
28.57% |
2024-06-25 |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
11.55% |
13.35% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
9.81% |
17.81% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.71% |
9.54% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.83% |
9.66% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9% |
-12.43% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
11.54% |
15.15% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
10.71% |
-1.46% |
2024-07-18 |
FGEN
FibroGen, Inc.
|
Sell |
-6.29% |
-0.97% |
2024-06-28 |
PODD
Insulet Corporation
|
Sell |
-5.93% |
0% |
2024-07-19 |
The percentage of cash held in the portfolio is:
28.09%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
7.35% |
WST |
Sell
All
|
-5.09% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
11.05% |
33.48% |
2024-06-25 |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
11.41% |
15.55% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
9.83% |
10.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
9.94% |
23.12% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.92% |
15.37% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.91% |
13.92% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.98% |
0.13% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.45% |
7.58% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
10.24% |
-1.88% |
2024-07-12 |
RCM
R1 RCM Inc.
|
Buy |
10.54% |
0% |
2024-07-18 |
FGEN
FibroGen, Inc.
|
Sell |
-6.27% |
-3.88% |
2024-06-28 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
Assets Rebalanced
None